## Abstract The biosynthesis of aldolase A and B subunits has been studied in rat liver during the administration of carcinogen AAFThe abbreviations used in this paper are: FDP — fructose‐1,6‐diphosphate; F‐1‐P — fructose‐1‐phosphate; AAF — 2‐acetylaminofluorenea . Transition from a predominance o
Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis
✍ Scribed by Volodymyr P. Tryndyak; Olga Kovalchuk; Levan Muskhelishvili; Beverly Montgomery; Rocio Rodriguez-Juarez; Stepan Melnyk; Sharon A. Ross; Frederick A. Beland; Igor P. Pogribny
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 351 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0899-1987
- DOI
- 10.1002/mc.20263
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Tamoxifen, a nonsteroidal anti‐estrogen, is a potent genotoxic hepatocarcinogen in rats, with both tumor initiating and promoting properties. Recently it has been demonstrated that genotoxic carcinogens, in addition to exerting genotoxic effects, often cause epigenetic alterations and these induced epigenetic changes may play important mechanistic role in carcinogenesis. In the present study, we investigated the role of tamoxifen‐induced epigenetic changes in hepatocarcinogenic process. The results of the study showed that exposure of female F344 rats to tamoxifen resulted in progressive loss of CpG methylation in regulatory sequences of long interspersed nucleotide elements (LINE‐1) and prominent increase in expression of LINE‐1 elements and c‐myc proto‐oncogene. The accumulation of tamoxifen‐induced DNA lesions was accompanied by the decreased level of Rad51, Ku70, and DNA polymerase β (Polβ) proteins that play a crucial role in maintenance of genomic stability. Furthermore, feeding rats with tamoxifen‐containing diet led to increased regenerative cell proliferation, as indicated by the increased level of Ki‐67 and proliferating cell nuclear antigen (PCNA) proteins. These data indicate that exposure of animals to genotoxic hepatocarcinogen tamoxifen led to early phenotypical alterations in livers characterized by emergence of epigenetically reprogrammed cells with a specific cancer‐related epigenetic phenotype prior to tumor formation. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Tamoxifen, an important drug in breast cancer treatment, causes liver cancer in rats. The standard range of in vitro tests have failed to show that it causes DNA damage, but 32P-postlabelling and DNA-binding studies have shown that tamoxifen forms DNA adducts in rat liver. In 1995 a transgenic rat (
To evaluate the application of Ha-ras mRNA antisense oligonucleotide therapy for liver tumors, we examined the frequency and types of mutation in codon 61 of the Ha-ras oncogene in preneoplastic lesions and hepatocellular carcinomas induced by N-nitrosomorpholine (NNM) in rats. Thirtyseven percent o
to a selective reduction of the liver load with preneoplas-Previous studies have shown 5-to 10-fold higher rates tic cells. (HEPATOLOGY 1996;23:840-847.) of apoptosis in prestages of liver cancer (putative preneoplastic cell foci [PPF]) than in unaltered liver; fasting or withdrawal of tumor promote
The biological significance of phosphatidylcholine-specific phospholipase C (PC-PLC) in hepatocarcinogenesis and the proliferation and differentiation of rat liver cancer cells was investigated. The Ca 2+ -dependent activities of PC-PLC gradually increased during N-nitrosodiethylamine (DEN)-induced